Sign in

CIK 0001863127

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Tyra Biosciences, Inc.

Sign in to watch
Ticker
TYRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831476348
Phone
+1 619-728-4760
Business address
2656 STATE STREET, CARLSBAD, CA, 92008
Open-market buys, last 90 days
$20,000
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Verjee Rehan +$20K Director 1 filing
Date Insider Transaction Shares Price Value Owned after
2026-05-28 MORE ROBERT J Director Grant or award · Stock Option (Right to Buy) +13,160 13,160
2025-12-19 MORE ROBERT J Director Sale 10b5-1 −10,000 $25.00 $250K 3,823,425
2025-11-21 MORE ROBERT J Director Sale 10b5-1 −246,871 $20.25 $5.0M 3,833,425
2025-05-29 MORE ROBERT J Director Grant or award · Stock Option (Right to Buy) +22,200 22,200
2024-05-29 MORE ROBERT J Director Grant or award · Stock Option (Right to Buy) +18,600 18,600
2023-05-31 MORE ROBERT J Director Grant or award · Stock Option (Right to Buy) +14,500 14,500
2022-06-13 MORE ROBERT J Director Grant or award · Stock Option (Right to Buy) +14,500 14,500
2021-09-17 MORE ROBERT J Director Conversion +3,811,117 3,924,046
2021-09-17 MORE ROBERT J Director Purchase +156,250 $16.00 $2.5M 4,080,296
2021-09-17 MORE ROBERT J Director Conversion · Series A Preferred Stock −1,212,122 0
2021-09-17 MORE ROBERT J Director Conversion · Series B Preferred Stock −255,160 0

Page 1 of 1 · 11 trades